FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
What is the most strategic way to allocate preference signals and expressed geographic preferences in the residency match? Gimme an hour of your time and…
View this file, and add comments too.
Background Supplementary search methods, including citation searching, are essential if systematic reviews are to avoid producing biased conclusions. Little evidence exists on how to prioritise…
I am glad to hear that the Vatican is issueing new guidelines on supernatural phenomena. The document, compiled by the Vaticanās Dicastery for the Doctrine…
Does it feel right View as Webpage Share This Email Share This Email Share This Email Latest Health News Weather IHSCM Academy of Fab’ Stuff…
Governments issue health warnings as schools shut and crops fail, with fears that worse is to come as heatwave tightens grip
EMDR v. other psychological therapies for PTSD: a systematic review and individual participant data meta-analysis
I.M. Matters from ACP provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities…
Press release on the Radiation Oncology Case Rate (ROCR) Value-Based Program Act of 2024
Nature Reviews Drug Discovery – Secondary pharmacology screening of investigational small-molecule drugs for potentially adverse off-target activities is now standard practice in pharmaceutical…